- Report
- January 2024
- 200 Pages
Global
From €4826EUR$5,000USD£4,140GBP
- Report
- May 2018
- 124 Pages
Global
From €4778EUR$4,950USD£4,098GBP
- Report
- December 2019
- 25 Pages
Global
From €953EUR$988USD£818GBP
€1906EUR$1,975USD£1,635GBP
- Report
- February 2022
- 220 Pages
Global
From €5953EUR$6,168USD£5,107GBP
- Book
- April 2013
- 320 Pages
- Book
- September 2010
- 418 Pages
- Book
- November 2008
- 288 Pages
The Stem Cell Development market is a subset of the Drug Discovery industry, focusing on the development of stem cells for therapeutic and research purposes. Stem cells are unspecialized cells that can differentiate into specialized cells, and are used to study the development of tissues and organs, as well as to develop treatments for diseases. Companies in this market are involved in the research, development, and production of stem cell-based therapies, as well as the development of stem cell-based research tools.
The Stem Cell Development market is driven by advances in stem cell research, as well as the increasing demand for stem cell-based therapies. Companies in this market are also investing in the development of new technologies to improve the efficiency and efficacy of stem cell-based therapies.
Some companies in the Stem Cell Development market include Thermo Fisher Scientific, Merck KGaA, Lonza Group, and Cellular Dynamics International. Show Less Read more